Skip to content
Open access · OA via OpenAlex

Genetically enhanced mesenchymal stem cells for aging intervention

Jing-Hui LEI, Guang-Hui LIU, Si Wang

Shengming kexue · 2026

Abstract

Aging is an inevitable physiological process accompanied by a gradual decline in the function of adult stem cells, which is widely recognized as a core factor of various aging-related diseases, including cardiovascular diseases, diabetes, neurodegenerative diseases and osteoporosis. Mesenchymal stem cells (MSCs), due to their advantages such as multilineage differentiation potential, immunomodulatory capacity, and low immunogenicity, are considered the most promising cell transplantation materials for delaying aging and promoting regeneration. However, after transplantation, MSCs often face extremely low survival rates and short retention times in the harsh microenvironment of the aging body, which is characterized by oxidative stress, chronic inflammation, accumulation of toxic metabolites and reduced nutrient supply, severely limiting their therapeutic efficacy in clinical applications. To address this critical bottleneck, genetic enhancement strategies have emerged as a promising solution, which employ precise gene editing technologies such as CRISPR-Cas9 <?A3B2 pi129?>to modify target genes, thereby improving the homing ability of MSCs to damaged tissues, enhancing their resistance to adverse microenvironmental stress, and promoting their paracrine secretion of beneficial cytokines. These genetically enhanced MSCs show markedly superior therapeutic efficacy relative to wild-type MSCs in the treatment of aging and related diseases. Although the long-term safety and potential risks of genetically enhanced MSCs still require further evaluation through large-sample, long-term preclinical and clinical studies, they undoubtedly represent an important breakthrough direction for the development of next-generation safe and effective anti-aging therapies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3724/cbls.2026094
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
LEI, J., LIU, G., &amp; Wang, S. (2026). Genetically enhanced mesenchymal stem cells for aging intervention. <em>Shengming kexue</em>. https://doi.org/10.3724/cbls.2026094
Vancouver
LEI J, LIU G, Wang S. Genetically enhanced mesenchymal stem cells for aging intervention. Shengming kexue. 2026. doi:10.3724/cbls.2026094.
BibTeX
@article{jinghui2026Geneti, title = {Genetically enhanced mesenchymal stem cells for aging intervention}, author = {Jing-Hui LEI and Guang-Hui LIU and Si Wang}, journal = {Shengming kexue}, year = {2026}, doi = {10.3724/cbls.2026094}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings